Autolus Therapeutics plc (AUTL) Earnings History
Annual and quarterly earnings data from 2015 to 2024
Loading earnings history...
AUTL EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
AUTL Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | -1293.5% | -2385.6% | -2180.5% |
| 2023 | 100.0% | -10583.1% | -12272.3% |
| 2022 | 100.0% | -2307.0% | -2403.0% |
| 2021 | 100.0% | -9314.8% | -9429.1% |
| 2020 | -7765.2% | -17675.4% | -8285.4% |
Download Data
Export AUTL earnings history in CSV or JSON format
Free sign-in required to download data
Autolus Therapeutics plc (AUTL) Earnings Overview
As of May 8, 2026, Autolus Therapeutics plc (AUTL) reported trailing twelve-month net income of -$225M, reflecting +27.5% year-over-year growth. The company earned $-0.84 per diluted share over the past four quarters, with a net profit margin of -2180.5%.
Looking at the long-term picture, AUTL's historical earnings data spans multiple years. The company achieved its highest annual net income of -$7M in fiscal 2015.
Autolus Therapeutics plc is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including KYMR (-$315M net income, -794.4% margin), FATE (-$136M net income, -2051.1% margin), CRSP (-$569M net income, -16569.8% margin), AUTL has room to improve margins relative to the peer group. Compare AUTL vs KYMR →
AUTL Earnings vs Peers
Earnings metrics vs comparable public companies
AUTL Historical Earnings Data (2015–2024)
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$221M | -5.9% | -$241M | $-0.87 | -2180.5% | -2385.6% |
| 2023 | -$208M | -40.0% | -$180M | $-1.20 | -12272.3% | -10583.1% |
| 2022 | -$149M | -4.7% | -$143M | $-1.57 | -2403.0% | -2307.0% |
| 2021 | -$142M | -0.0% | -$140M | $-1.97 | -9429.1% | -9314.8% |
| 2020 | -$142M | -14.7% | -$303M | $-2.76 | -8285.4% | -17675.4% |
| 2019 | -$124M | -298.0% | -$248M | $-2.88 | -4258.9% | -8513.8% |
| 2018 | -$31M | -57.7% | -$58M | $-0.99 | -2976.5% | -5503.7% |
| 2017 | -$20M | -57.2% | -$23M | $-1.43 | -1165.2% | -1383.2% |
| 2016 | -$13M | -68.1% | -$14M | $-0.91 | -1035.5% | -1186.1% |
| 2015 | -$7M | - | -$8M | $-0.54 | -7931.1% | -8613.8% |
See AUTL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AUTL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AUTL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAUTL — Frequently Asked Questions
Quick answers to the most common questions about buying AUTL stock.
Is AUTL growing earnings?
AUTL EPS is $-0.84, with earnings growth accelerating to +27.5%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-225M.
What are AUTL's profit margins?
Autolus Therapeutics plc net margin is -2180.5%, with operating margin at -2385.6%. Below-average margins reflect competitive or cost pressures.
How consistent are AUTL's earnings?
AUTL earnings data spans 2015-2024. The accelerating earnings trend is +27.5% YoY. Historical data enables comparison across business cycles.